 | • レポートコード：MRC2102QY5443 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のインフルエンザワクチン市場について種類別（三価インフルエンザワクチン、四価インフルエンザワクチン）、用途別（子供（6ヶ月〜3歳）、大人・子供3歳以上）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・インフルエンザワクチン市場の概要 ・世界の主要地域別インフルエンザワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のインフルエンザワクチン市場規模2015-2026：種類別（三価インフルエンザワクチン、四価インフルエンザワクチン） ・世界のインフルエンザワクチン市場規模2015-2026：用途別（子供（6ヶ月〜3歳）、大人・子供3歳以上） ・インフルエンザワクチンの米国市場規模2015-2020 ・インフルエンザワクチンのヨーロッパ市場規模2015-2020 ・インフルエンザワクチンの中国市場規模2015-2020 ・インフルエンザワクチンの日本市場規模2015-2020 ・インフルエンザワクチンの東南アジア市場規模2015-2020 ・インフルエンザワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・インフルエンザワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・インフルエンザワクチンの市場動向・機会・課題 ・調査の結論 |
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The industry’s leading producers are Sanofi Pasteur, CSL and GSK, with revenue ratios of 44.94%, 25.37% and 14.70%, respectively, in 2019.
Market Analysis and Insights: Global Flu Vaccine Market
The global Flu Vaccine market size is projected to reach US$ 6836.7 million by 2026, from US$ 5154.4 million in 2020, at a CAGR of 4.8% during 2021-2026.
Global Flu Vaccine Scope and Market Size
The global Flu Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Flu Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Flu Vaccine market is segmented into
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application, the Flu Vaccine market is segmented into
For Children (6 months to 3 years)
For Adults and Children over 3 years
The Flu Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Flu Vaccine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Flu Vaccine Market Share Analysis
Flu Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Flu Vaccine business, the date to enter into the Flu Vaccine market, Flu Vaccine product introduction, recent developments, etc.
The major vendors covered:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
1 Flu Vaccine Market Overview
1.1 Flu Vaccine Product Scope
1.2 Flu Vaccine Segment by Type
1.2.1 Global Flu Vaccine Sales by Type (2020-2026)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Flu Vaccine Segment by Application
1.3.1 Global Flu Vaccine Sales Comparison by Application (2020-2026)
1.3.2 For Children (6 months to 3 years)
1.3.3 For Adults and Children over 3 years
1.4 Flu Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Flu Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Flu Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Flu Vaccine Price Trends (2015-2026)
2 Flu Vaccine Estimate and Forecast by Region
2.1 Global Flu Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Flu Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Flu Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Flu Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Flu Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Flu Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Flu Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Flu Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Flu Vaccine Estimates and Projections (2015-2026)
2.4.3 China Flu Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Flu Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Flu Vaccine Estimates and Projections (2015-2026)
2.4.6 India Flu Vaccine Estimates and Projections (2015-2026)
3 Global Flu Vaccine Competition Landscape by Players
3.1 Global Top Flu Vaccine Players by Sales (2015-2020)
3.2 Global Top Flu Vaccine Players by Revenue (2015-2020)
3.3 Global Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2019)
3.4 Global Flu Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Flu Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Flu Vaccine Players (Opinion Leaders)
4 Global Flu Vaccine Market Size by Type
4.1 Global Flu Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Flu Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Flu Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Flu Vaccine Price by Type (2015-2020)
4.2 Global Flu Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Flu Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Flu Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Flu Vaccine Price Forecast by Type (2021-2026)
5 Global Flu Vaccine Market Size by Application
5.1 Global Flu Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Flu Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Flu Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Flu Vaccine Price by Application (2015-2020)
5.2 Global Flu Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Flu Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Flu Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Flu Vaccine Price Forecast by Application (2021-2026)
6 United States Flu Vaccine Market Facts & Figures
6.1 United States Flu Vaccine Sales Market Share by Company (2015-2020)
6.2 United States Flu Vaccine Sales Market Share by Type (2015-2020)
6.3 United States Flu Vaccine Sales Market Share by Application (2015-2020)
7 Europe Flu Vaccine Market Facts & Figures
7.1 Europe Flu Vaccine Sales Market Share by Company (2015-2020)
7.2 Europe Flu Vaccine Sales Market Share by Type (2015-2020)
7.3 Europe Flu Vaccine Sales Market Share by Application (2015-2020)
8 China Flu Vaccine Market Facts & Figures
8.1 China Flu Vaccine Sales Market Share by Company (2015-2020)
8.2 China Flu Vaccine Sales Market Share by Type (2015-2020)
8.3 China Flu Vaccine Sales Market Share by Application (2015-2020)
9 Japan Flu Vaccine Market Facts & Figures
9.1 Japan Flu Vaccine Sales Market Share by Company (3015-3030)
9.2 Japan Flu Vaccine Sales Market Share by Type (2015-2020)
9.3 Japan Flu Vaccine Sales Market Share by Application (2015-2020)
10 Southeast Asia Flu Vaccine Market Facts & Figures
10.1 Southeast Asia Flu Vaccine Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Flu Vaccine Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Flu Vaccine Sales Market Share by Application (2015-2020)
11 India Flu Vaccine Market Facts & Figures
11.1 India Flu Vaccine Sales Market Share by Company (2015-2020)
11.2 India Flu Vaccine Sales Market Share by Type (2015-2020)
11.3 India Flu Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Flu Vaccine Business
12.1 Sanofi Pasteur
12.1.1 Sanofi Pasteur Corporation Information
12.1.2 Sanofi Pasteur Business Overview
12.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Pasteur Flu Vaccine Products Offered
12.1.5 Sanofi Pasteur Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Flu Vaccine Products Offered
12.2.5 CSL Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Business Overview
12.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GSK Flu Vaccine Products Offered
12.3.5 GSK Recent Development
12.4 Mylan
12.4.1 Mylan Corporation Information
12.4.2 Mylan Business Overview
12.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Mylan Flu Vaccine Products Offered
12.4.5 Mylan Recent Development
12.5 Hulan Bio
12.5.1 Hulan Bio Corporation Information
12.5.2 Hulan Bio Business Overview
12.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hulan Bio Flu Vaccine Products Offered
12.5.5 Hulan Bio Recent Development
12.6 AstraZeneca
12.6.1 AstraZeneca Corporation Information
12.6.2 AstraZeneca Business Overview
12.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 AstraZeneca Flu Vaccine Products Offered
12.6.5 AstraZeneca Recent Development
12.7 CCBIO
12.7.1 CCBIO Corporation Information
12.7.2 CCBIO Business Overview
12.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 CCBIO Flu Vaccine Products Offered
12.7.5 CCBIO Recent Development
…
13 Flu Vaccine Manufacturing Cost Analysis
13.1 Flu Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Flu Vaccine
13.4 Flu Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Flu Vaccine Distributors List
14.3 Flu Vaccine Customers
15 Market Dynamics
15.1 Flu Vaccine Market Trends
15.2 Flu Vaccine Opportunities and Drivers
15.3 Flu Vaccine Market Challenges
15.4 Flu Vaccine Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Flu Vaccine Sales (M Doses) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Flu Vaccine Sales (M Doses) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Flu Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Flu Vaccine Sales (M Doses) by Region (2015-2020)
Table 5. Global Flu Vaccine Sales Market Share by Region (2015-2020)
Table 6. Global Flu Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Flu Vaccine Revenue Share by Region (2015-2020)
Table 8. Global Flu Vaccine Sales (M Doses) Forecast by Region (2021-2026)
Table 9. Global Flu Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Flu Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Flu Vaccine Revenue Share Forecast by Region (2021-2026)
Table 12. Global Flu Vaccine (M Doses) of Key Companies (2015-2020)
Table 13. Global Flu Vaccine Sales Share by Company (2015-2020)
Table 14. Global Flu Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Flu Vaccine Revenue Share by Company (2015-2020)
Table 16. Global Flu Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu Vaccine as of 2019)
Table 17. Global Flu Vaccine Average Price (US$/Dose) of Key Company (2015-2020)
Table 18. Manufacturers Flu Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Flu Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Flu Vaccine Players
Table 22. Global Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 23. Global Flu Vaccine Sales Share by Type (2015-2020)
Table 24. Global Flu Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Flu Vaccine Price (M Doses) by Type (2015-2020)
Table 26. Global Flu Vaccine Sales Share by Type (2021-2026)
Table 27. Global Flu Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Flu Vaccine Revenue Share by Type (2021-2026)
Table 29. Global Flu Vaccine Price (M Doses) by Type (2021-2026)
Table 30. Global Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 31. Global Flu Vaccine Sales Share by Application (2015-2020)
Table 32. Global Flu Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Flu Vaccine Price (M Doses) by Application (2015-2020)
Table 34. Global Flu Vaccine Sales (M Doses) by Application (2021-2026)
Table 35. Global Flu Vaccine Sales Share by Application (2021-2026)
Table 36. Global Flu Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Flu Vaccine Revenue Share by Application (2021-2026)
Table 38. Global Flu Vaccine Price (M Doses) by Application (2021-2026)
Table 39. United States Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 40. United States Flu Vaccine Sales Market Share by Company (2015-2020)
Table 41. United States Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 42. United States Flu Vaccine Sales Market Share by Type (2015-2020)
Table 43. United States Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 44. United States Flu Vaccine Sales Market Share by Application (2015-2020)
Table 45. Europe Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 46. Europe Flu Vaccine Sales Market Share by Company (2015-2020)
Table 47. Europe Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 48. Europe Flu Vaccine Sales Market Share by Type (2015-2020)
Table 49. Europe Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 50. Europe Flu Vaccine Sales Market Share by Type (2015-2020)
Table 51. China Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 52. China Flu Vaccine Sales Market Share by Company (2015-2020)
Table 53. China Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 54. China Flu Vaccine Sales Market Share by Type (2015-2020)
Table 55. China Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 56. China Flu Vaccine Sales Market Share by Application (2015-2020)
Table 57. Japan Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 58. Japan Flu Vaccine Sales Market Share by Company (2015-2020)
Table 59. Japan Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 60. Japan Flu Vaccine Sales Market Share by Type (2015-2020)
Table 61. Japan Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 62. Japan Flu Vaccine Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 64. Southeast Asia Flu Vaccine Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 66. Southeast Asia Flu Vaccine Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 68. Southeast Asia Flu Vaccine Sales Market Share by Application (2015-2020)
Table 69. India Flu Vaccine Sales (M Doses) by Company (2015-2020)
Table 70. India Flu Vaccine Sales Market Share by Company (2015-2020)
Table 71. India Flu Vaccine Sales (M Doses) by Type (2015-2020)
Table 72. India Flu Vaccine Sales Market Share by Type (2015-2020)
Table 73. India Flu Vaccine Sales (M Doses) by Application (2015-2020)
Table 74. India Flu Vaccine Sales Market Share by Application (2015-2020)
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 78. Sanofi Pasteur Flu Vaccine Product
Table 79. Sanofi Pasteur Recent Development
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 83. CSL Flu Vaccine Product
Table 84. CSL Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 88. GSK Flu Vaccine Product
Table 89. GSK Recent Development
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 93. Mylan Flu Vaccine Product
Table 94. Mylan Recent Development
Table 95. Hulan Bio Corporation Information
Table 96. Hulan Bio Description and Business Overview
Table 97. Hulan Bio Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 98. Hulan Bio Flu Vaccine Product
Table 99. Hulan Bio Recent Development
Table 100. AstraZeneca Corporation Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 103. AstraZeneca Flu Vaccine Product
Table 104. AstraZeneca Recent Development
Table 105. CCBIO Corporation Information
Table 106. CCBIO Description and Business Overview
Table 107. CCBIO Flu Vaccine Sales (M Doses), Revenue (Million USD), Price (US$/Dose) and Gross Margin (2015-2020)
Table 108. CCBIO Flu Vaccine Product
Table 109. CCBIO Recent Development
Table 110. Production Base and Market Concentration Rate of Raw Material
Table 111. Key Suppliers of Raw Materials
Table 112. Flu Vaccine Distributors List
Table 113. Flu Vaccine Customers List
Table 114. Flu Vaccine Market Key Trends
Table 115. Flu Vaccine Key Opportunities and Drivers
Table 116. Flu Vaccine Market Challenges
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Flu Vaccine Product Picture
Figure 2. Global Flu Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Flu Vaccine Market Share by Application in 2020 & 2026
Figure 6. For Children (6 months to 3 years) Examples
Figure 7. For Adults and Children over 3 years Examples
Figure 8. Global Flu Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 9. Global Flu Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Flu Vaccine Price Trends Growth Rate (2015-2026) (US$/Dose)
Figure 11. Global Flu Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Flu Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Flu Vaccine Sales (M Doses) Growth Rate (2015-2026)
Figure 15. Europe Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Flu Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Flu Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Flu Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Flu Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Flu Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Flu Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Flu Vaccine Players Market Share by Revenue in Flu Vaccine 2015 & 2019
Figure 26. Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Flu Vaccine Revenue Share by Type (2015-2020)
Figure 28. Global Flu Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Flu Vaccine Revenue Share by Application (2015-2020)
Figure 30. Global Flu Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Flu Vaccine Sales Market Share by Type in 2019
Figure 32. United States Flu Vaccine Sales Market Share by Type in 2019
Figure 33. Europe Flu Vaccine Sales Market Share by Company in 2019
Figure 34. Europe Flu Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Flu Vaccine Sales Market Share by Application in 2019
Figure 36. China Flu Vaccine Sales Market Share by Company in 2019
Figure 37. China Flu Vaccine Sales Market Share by Type in 2019
Figure 38. China Flu Vaccine Sales Market Share by Application in 2019
Figure 39. Japan Flu Vaccine Sales Market Share by Company in 2019
Figure 40. Japan Flu Vaccine Sales Market Share by Type in 2019
Figure 41. Japan Flu Vaccine Sales Market Share by Application in 2019
Figure 42. Southeast Asia Flu Vaccine Sales Market Share by Company in 2019
Figure 43. Southeast Asia Flu Vaccine Sales Market Share by Type in 2019
Figure 44. Southeast Asia Flu Vaccine Sales Market Share by Application in 2019
Figure 45. India Flu Vaccine Sales Market Share by Company in 2019
Figure 46. India Flu Vaccine Sales Market Share by Type in 2019
Figure 47. India Flu Vaccine Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Flu Vaccine
Figure 50. Manufacturing Process Analysis of Flu Vaccine
Figure 51. Flu Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
23価肺炎球菌多糖体ワクチンの世界市場レポート2020 23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine is for use only in …- 麻疹（はしか）ワクチンの世界市場レポート2020 Measles vaccine is made by inoculation of attenuated strain of measles virus into chicken embryo cells, culture and harvesting of virus venom, and then freeze-drying. Injection into the lateral deltoid muscle attachment of the upper arm can prevent measles. Market Analysis and Insights: Global Measl…
- ワクチン用コンジュゲートの世界市場レポート2020 Market Analysis and Insights: Global Vaccine Conjugate Market The global Vaccine Conjugate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Vaccine Conjugate Scope and Market Size The global Vaccine Conjugate market is s…
- 点鼻ワクチンの世界市場レポート2020 Nasal Spray Vaccine refers to a vaccine injected through the nose, which is mostly used for influenza. The FluMist is the only alternative to the flu shot without a needle and is given in the form of a nasal spray. Nasal Spray Vaccine is widely sales for Child and Adult The most proportion of Nasal …
- 水痘ワクチンの世界市場レポート2020 Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to c…